iXCells Biotechnologies, a provider of human cell-based solutions and custom iPSC services, has appointed Steve Smith as CEO. Previously CCO, Smith will lead the Company to advance execution and delivery of iXCells’ bespoke human-derived iPSC preclinical services as demand increases for scalable, high-quality, and human relevant preclinical models. “Steve’s appointment marks a pivotal moment for iXCells,” said Alex Gulotta, Principal at Great Point Partners. “His strategic vision and deep ...